GrantUp
NIHRCloses in 14 daysIncluded in GrantPartner*

Stage 1 NICE: i4i Product Development Awards (PDA) NICE early use

Applications must come from a consortium whose evaluation partner is a UK legal entity and leads the work to generate evidence. The consortium must also include the product provider as technology partner and at least one NHS site or service adopting the product. Eligible products must already have a published NICE recommendation for early use in the NHS.

Funding
No specified limit
Closes
2 December 2026
Applicants
Collaborative
Applications must come from a consortium. Its evaluation partner must be a UK legal entity and lead the evidence generation work. Confirm formal lead applicant requirements in the official brief.
Funder
NIHR
Official brief

What this competition funds

  • Evidence generation for products that already have a published NICE recommendation for early use in the NHS.
  • Collaborative evaluation involving the product provider and at least one NHS site or service adopting the product.
  • Life sciences and health projects at feasibility or industrial R&D stages, with specific eligible activities to be confirmed in the official brief.

Who can apply?

Lead applicant
Applications must come from a consortium. Its evaluation partner must be a UK legal entity and lead the evidence generation work. Confirm formal lead applicant requirements in the official brief.
Partners and collaborators
The consortium must include the product provider as technology partner and at least one NHS site or service adopting the product.
Worth checking
The opportunity is UK-wide. Products must already have a published NICE recommendation for early use in the NHS.
Life sciences & healthFeasibilityIndustrial R&D

What assessors look for

01

Need and evidence challenge

Identify the evidence questions your evaluation will address and link them to the product's published NICE early use recommendation. Confirm the call's formal assessment criteria in the official brief.

02

Innovation and product fit

Explain the product's role in NHS care and demonstrate that it meets the NICE early use requirement. Distinguish the proposed evidence generation from further product development.

03

Impact and value for money

Explain how the evidence could inform NHS use of the product. Connect each budget item to the evaluation work and justify the funding requested despite there being no specified award limit.

04

Delivery and team

Set out how the UK evaluation partner will lead evidence generation, with clear responsibilities for the technology partner and NHS adopter. Explain how the consortium will coordinate evaluation and adoption activity.

Where applications usually lose marks

  • Failing to demonstrate that the product already has a published NICE recommendation for early use in the NHS.
  • Leaving the evaluation partner's legal status or evidence generation leadership unclear, or omitting a required consortium participant.
  • Presenting an evaluation plan or budget without a clear connection to the evidence questions and the adopting NHS site or service.

How GrantUp can help

Our specialist bid writers build the scoring case, budget and narrative with you, with an over 82% success rate per engagement and over £190m secured for clients. Grant funding engagements have a minimum upfront setup fee starting from £1,750, plus a success fee payable on award. The scope and success fee are agreed before work starts. We do not take equity.

This competition is also covered by GrantPartner. GrantPartner is a paid six month grant programme with the cost spread in monthly payments, a rolling portfolio of bids and a success fee on award. If no funding is awarded during the programme, we extend it.

Discuss this grant

Frequently asked questions

How much funding is available?

The listing specifies no award limit and gives a funding rate of 100%. Total funding is not stated. Applicants should confirm eligible costs, any funding conditions and how the rate applies to consortium members in the official brief.

Which products and applicants are eligible?

Eligible products must already have a published NICE recommendation for early use in the NHS. Applications must come from a consortium whose evaluation partner is a UK legal entity and leads evidence generation. The opportunity is UK-wide; confirm any additional eligibility requirements in the official brief.

Which collaborators must be involved?

The consortium must include an evaluation partner that is a UK legal entity, the product provider as technology partner, and at least one NHS site or service adopting the product. The evaluation partner must lead evidence generation. Confirm any further collaboration requirements in the official brief.

How do we apply?

This listing is for Stage 1. Start by checking the official brief for the application route, required documents and formal lead applicant rules. Prepare a clear account of the product's NICE early use recommendation, the consortium's roles and the proposed evidence generation work.

Programme at a glance

Funding
No specified limit
Funder
NIHR
Region
UK-wide
Partners required
Yes
Next deadline
2 December 2026

Why GrantUp

  • Over 82% success rate per engagement
  • Over £190m secured for clients
  • Specialist technical bid writers
Book a screening call

Considering Stage 1 NICE: i4i Product Development Awards (PDA) NICE early use?

Talk through your project with a specialist and find out whether this is the right competition before you invest time in an application.